US Stock MarketDetailed Quotes

LBPS 4D pharma

Watchlist
  • 1.650
  • 0.0000.00%
Close Oct 11 09:30 ET
37.19MMarket Cap-1164P/E (TTM)

4D pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
Total revenue
-2.25%522K
160.28%534K
205.16K
0
Operating revenue
-2.25%522K
160.28%534K
--205.16K
--0
----
Cost of revenue
Gross profit
Operating expense
-3.27%27.05M
-7.34%27.97M
-2.11%30.18M
51.43%30.83M
20.36M
Selling and administrative expenses
19.78%4.91M
-48.26%4.1M
-11.05%7.92M
318.26%8.9M
--2.13M
-General and administrative expense
19.78%4.91M
-48.26%4.1M
-11.05%7.92M
318.26%8.9M
--2.13M
Research and development costs
-10.09%19.82M
-1.01%22.04M
1.52%22.26M
29.69%21.93M
--16.91M
-Depreciation and amortization
-18.37%231K
--283K
----
----
--67K
Operating profit
3.29%-26.53M
8.49%-27.43M
2.78%-29.98M
-51.43%-30.83M
-20.36M
Net non-operating interest income expense
-262.50%-609K
-382.40%-168K
-79.92%59.49K
-17.46%296.32K
359K
Non-operating interest income
-80.00%1K
-91.60%5K
-80.08%59.49K
-38.03%298.68K
--482K
Non-operating interest expense
252.60%610K
--173K
----
-98.08%2.36K
--123K
Other net income (expense)
Special income (charges)
-1,327.49%-44.4M
-237.44%-3.11M
717.50%2.26M
89.69%-366.46K
---3.55M
-Less:Restructuring and merger&acquisition
1,327.04%44.38M
237.44%3.11M
-717.50%-2.26M
-89.45%366.46K
--3.47M
-Less:Other special charges
--14K
----
----
----
--79K
Other non- operating income (expenses)
----
----
4.44%5.25M
--5.03M
----
Income before tax
-89.37%-57.47M
-31.17%-30.35M
9.96%-23.13M
-7.11%-25.69M
-23.99M
Income tax
20.03%-3.51M
-4.38M
0
0
-3.54M
Net income
-107.83%-53.96M
-12.23%-25.96M
9.96%-23.13M
-25.66%-25.69M
-20.45M
Net income continuous Operations
-107.83%-53.96M
-12.23%-25.96M
9.96%-23.13M
-25.66%-25.69M
---20.45M
Minority interest income
Net income attributable to the parent company
-107.83%-53.96M
-12.23%-25.96M
9.96%-23.13M
-25.66%-25.69M
-20.45M
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
Net income attributable to common stockholders
-107.83%-53.96M
-12.23%-25.96M
9.96%-23.13M
-25.66%-25.69M
-20.45M
Basic earnings per share
-39.61%-2.5464
35.01%-1.824
10.97%-2.8067
-25.45%-3.1523
-2.5128
Diluted earnings per share
-39.61%-2.5464
35.01%-1.824
10.97%-2.8067
-25.45%-3.1523
-2.5128
Dividend per share
Currency Unit
GBP
GBP
GBP
GBP
GBP
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017
Total revenue -2.25%522K160.28%534K205.16K0
Operating revenue -2.25%522K160.28%534K--205.16K--0----
Cost of revenue
Gross profit
Operating expense -3.27%27.05M-7.34%27.97M-2.11%30.18M51.43%30.83M20.36M
Selling and administrative expenses 19.78%4.91M-48.26%4.1M-11.05%7.92M318.26%8.9M--2.13M
-General and administrative expense 19.78%4.91M-48.26%4.1M-11.05%7.92M318.26%8.9M--2.13M
Research and development costs -10.09%19.82M-1.01%22.04M1.52%22.26M29.69%21.93M--16.91M
-Depreciation and amortization -18.37%231K--283K----------67K
Operating profit 3.29%-26.53M8.49%-27.43M2.78%-29.98M-51.43%-30.83M-20.36M
Net non-operating interest income expense -262.50%-609K-382.40%-168K-79.92%59.49K-17.46%296.32K359K
Non-operating interest income -80.00%1K-91.60%5K-80.08%59.49K-38.03%298.68K--482K
Non-operating interest expense 252.60%610K--173K-----98.08%2.36K--123K
Other net income (expense)
Special income (charges) -1,327.49%-44.4M-237.44%-3.11M717.50%2.26M89.69%-366.46K---3.55M
-Less:Restructuring and merger&acquisition 1,327.04%44.38M237.44%3.11M-717.50%-2.26M-89.45%366.46K--3.47M
-Less:Other special charges --14K--------------79K
Other non- operating income (expenses) --------4.44%5.25M--5.03M----
Income before tax -89.37%-57.47M-31.17%-30.35M9.96%-23.13M-7.11%-25.69M-23.99M
Income tax 20.03%-3.51M-4.38M00-3.54M
Net income -107.83%-53.96M-12.23%-25.96M9.96%-23.13M-25.66%-25.69M-20.45M
Net income continuous Operations -107.83%-53.96M-12.23%-25.96M9.96%-23.13M-25.66%-25.69M---20.45M
Minority interest income
Net income attributable to the parent company -107.83%-53.96M-12.23%-25.96M9.96%-23.13M-25.66%-25.69M-20.45M
Preferred stock dividends
Other preferred stock dividends 00000
Net income attributable to common stockholders -107.83%-53.96M-12.23%-25.96M9.96%-23.13M-25.66%-25.69M-20.45M
Basic earnings per share -39.61%-2.546435.01%-1.82410.97%-2.8067-25.45%-3.1523-2.5128
Diluted earnings per share -39.61%-2.546435.01%-1.82410.97%-2.8067-25.45%-3.1523-2.5128
Dividend per share
Currency Unit GBPGBPGBPGBPGBP
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg